Patent · US Active

Photonic blood typing

US9599613B2 · kind B2 · utility

2Cited by
142References
22Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJul 20, 2012
Grant dateMar 21, 2017
Priority date
Expiry dateJul 20, 2032

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N21/75
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Photonic devices, systems, and methods for detecting an analyte in a biological solution (e.g., whole blood) are provided. Representative photonic devices are optical ring resonators having nanoscale features and micron-sized diameters. Due to the compact size of these devices, many resonators can be disposed on a single substrate and tested simultaneously as a sample is passed over the devices. Typical analytes include blood cells, antibodies, and pathogens, as well as compounds indicative of the presence of blood cells or pathogens (e.g., serology). In certain embodiments, blood type can be determined through photonic sensing using a combination of direct detection of blood cells and serology. By combining the detection signals of multiple devices, the type of blood can be determined.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.